Back to Explorer

21CFR203.10

§ 203.10 Restrictions on reimportation.

Regulation Text

No prescription drug or drug composed wholly or partly of insulin that was manufactured in a State and exported from the United States may be reimported by anyone other than its manufacturer, except that FDA may grant permission to a person other than the manufacturer to reimport a prescription drug or insulin-containing drug if it determines that such reimportation is required for emergency medical care.

Authority

21 U.S.C. 331,333,351,352,353,360,371,374,381.

View in Graph Explorer